Ryan D Souza, MD
Pain Medicine · Rochester, MNNPI 1881042174
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (47.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Vertex at 53.0% of the total. 2025 is the largest year on record at $12,284, more than ten times the $270 reported in 2019.
Across 119 payments — averaging $173.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Vertex$11K
- Nevro Corp.$3K
- Medtronic$2K
- Boston Scientific$2K
- SPR Therapeutics, Inc$1K
- Nalu Medical, Inc.$477
- plus $2K from 14 others
Across 2 payments — averaging $6125.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Nevro Corp.$12K
What the payments were for
- Consulting fees$1251%
- Speaking & faculty fees$9,82548%
- Travel & lodging$2,07410%
- Food & beverage$8,34741%
- Education$2181%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Vertex | 10 | $10,919 |
| Nevro Corp. | 26 | $2,544 |
| Medtronic(2 entities) | 21 | $2,165 |
| Boston Scientific | 13 | $1,711 |
| SPR Therapeutics, Inc | 8 | $1,017 |
| Nalu Medical, Inc. | 6 | $477 |
| Globus Medical | 5 | $397 |
| Abbott | 4 | $374 |
| Stratus Medical, LLC | 1 | $158 |
| Avanos Medical | 1 | $153 |
| GRT US Holding, Inc. | 1 | $134 |
| Lilly USA, LLC | 9 | $131 |
| Tonix Medicines, Inc. | 1 | $77 |
| Vertos Medical, Inc. | 1 | $67 |
| AbbVie | 5 | $64 |
| Stryker | 1 | $57 |
| Saluda Medical Americas, Inc. | 2 | $53 |
| Novartis | 1 | $49 |
| Amarin Pharma, Inc. | 2 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- JOURNAVX$10,792
- Superion Indirect Decompression System$1,239
- Omnia$986
- Senza$901
- SPRINT PNS System$864
- INTELLIS ADAPTIVESTIM$669
- Nalu Neurostimulation System$239
- INCEPTIV$236
- Senza Spinal Cord Stimulation System$223
- INTELLIS$218
- SYNCHROMEDII$162
- Nimbus$158
- COOLIEF* COOLED RADIOFREQUENCY$153
- Qutenza$134
- Accurian$127
- SUPERION$121
- Proclaim IPG$114
How this compares
$20,588 in reported general payments places this provider in the 85th percentile of 88 pain medicine providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Rochester
- Jonathan HagedornRochester$83K
- Michael McEntireRochester$70K
- James WatsonRochester$7K
- Yeng HerRochester$5K
- Laura Matzke BittermanRochester$5K
- Elliot BlankespoorRochester$3K
- Casey ButlerRochester$3K
- Sierra McLeanRochester$2K
- Colin RockRochester$1K
- Michael BiesRochester$881
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.